News Daily News CVD Risk Twofold Higher in Patients With Cancer: ASPREE Michael O'Riordan September 27, 2024
News Daily News Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years Yael L. Maxwell June 26, 2024
News Daily News No Safety Concerns Seen With Inclisiran in Large ORION Analysis Michael O'Riordan December 06, 2023
News Daily News Early Coronary Heart Disease Linked to Later Dementia, Alzheimer’s Michael O'Riordan November 29, 2023
News Daily News More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA Michael O'Riordan July 18, 2023
News Daily News Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities Michael O'Riordan April 25, 2022
News Daily News Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention Michael O'Riordan March 30, 2022
News Daily News Absence of CAC May be Protective Even in Patients With Very High Cholesterol Michael O'Riordan February 14, 2022
News Daily News New Antithrombotic Revacept Fails to Reduce Myocardial Injury in PCI Yael L. Maxwell April 05, 2021
News Daily News Smoking, Drinking, and Drugs—All Signs Point to Earlier ASCVD Michael O'Riordan February 19, 2021
News Daily News Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic Michael O'Riordan January 12, 2021
News Daily News More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California Shelley Wood May 22, 2020
News Daily News P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention Yael L. Maxwell May 15, 2020
News Daily News Type 2 MI Linked to More CV Deaths, Even in Younger Patients Shelley Wood March 04, 2020
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Daily News Higher Risk of Intracranial Hemorrhage With Aspirin in Primary Prevention Michael O'Riordan May 20, 2019
News Daily News Prolonged DAPT Does Not Increase Mortality, Cancer Risk: More Evidence L.A. McKeown January 12, 2018
News Daily News CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition Michael O'Riordan August 04, 2017
News Daily News Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings Michael O'Riordan July 12, 2016
News Daily News Media Scrutiny Over Risks and Benefits of Statins Impacts Patient Use Michael O'Riordan June 28, 2016